Aquatic Capital Management’s Collegium Pharmaceutical COLL Stock Holding History

Aquatic Capital Management’s Portfolio COLL Stock Details COLL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$879K	Buy	24,271 +9,090	+60%	+$311K	0.03%	597
2026 Q1	$502K	Buy	15,181 +3,307	+28%	+$140K	0.01%	755
2025 Q4	$550K	Buy	11,874 +645	+6%	+$27K	0.02%	704
2025 Q3	$393K	Sell	11,229 -10,555	-48%	-$367K	0.01%	934
2025 Q2	$644K	Sell	21,784 -8,554	-28%	-$244K	0.01%	752
2025 Q1	$906K	Buy	30,338 +14,249	+89%	+$435K	0.02%	624
2024 Q4	$461K	Buy	+16,089	New	+$532K	0.01%	733
2024 Q2	–	Sell	-8,800	Closed	-$342K	–	1291
2024 Q1	$342K	Buy	+8,800	New	+$308K	0.01%	638
2023 Q3	–	Sell	-5,600	Closed	-$120K	–	1305
2023 Q2	$120K	Sell	5,600 -3,200	-36%	-$72.7K	0.01%	805
2023 Q1	$211K	Buy	+8,800	New	+$233K	0.01%	573
2022 Q1	–	Sell	-400	Closed	-$7K	–	1149
2021 Q4	$7K	Buy	+400	New	+$7.8K	0.01%	867

Other funds holding COLL

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return

Aquatic Capital Management's COLL Position: Q2 2026 in Review

Aquatic Capital Management increased its Collegium Pharmaceutical (COLL) stake by 60% in Q2 2026, buying an estimated $311K and bringing the position to 24,271 shares worth $879K. The position accounts for 0.03% of the portfolio, ranked #597.

Aquatic Capital Management first reported a position in COLL in Q4 2021 and has held it in 11 quarters since. The position peaked at $906K in Q1 2025. 279 funds tracked by Wall St. Rank hold COLL as of Q2 2026.

Aquatic Capital Management held 24,271 shares of Collegium Pharmaceutical worth $879K as of Q2 2026.
Aquatic Capital Management bought 9,090 Collegium Pharmaceutical shares in Q2 2026, an estimated $311K.
Collegium Pharmaceutical made up 0.03% of Aquatic Capital Management's portfolio in Q2 2026, its #597 holding.
Aquatic Capital Management first reported a position in Collegium Pharmaceutical in Q4 2021 and has held it in 11 quarters since.
Aquatic Capital Management's Collegium Pharmaceutical position peaked at $906K in Q1 2025.
279 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q2 2026.

Based on Aquatic Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.